NSI-189: A Comprehensive Overview of its Nootropic Properties
NSI-189 (also known as NSI-189 phosphate, NSI-189 free base, and NSI-189 40mg) is a novel nootropic compound that has been studied for its potential to improve cognitive function and mood. It is a synthetic derivative of the neurotransmitter pyrazine, and is believed to act as a neurogenic agent, stimulating the growth of new neurons in the hippocampus, a region of the brain associated with memory and learning.
NSI-189 has been studied in both animal and human trials, and has been found to have a number of potential benefits, including improved memory, increased focus and concentration, and improved mood. It has also been studied for its potential to treat depression, anxiety, and other mood disorders.
Positive Effects of NSI-189
- Improved memory
- Increased focus and concentration
- Improved mood
- Reduced symptoms of depression and anxiety
- Improved sleep quality
Possible Negative Effects of NSI-189
- Headache
- Nausea
- Insomnia
- Anxiety
- Agitation
Dosage Information
The recommended dosage of NSI-189 is 40mg per day, taken in two divided doses of 20mg each. It is important to note that NSI-189 is not approved by the FDA, and should only be taken under the supervision of a qualified healthcare professional.
History of NSI-189
NSI-189 was first developed by Neuralstem, Inc., a biopharmaceutical company based in Maryland. The compound was initially studied for its potential to treat depression, and was found to be effective in animal models. It was then studied in human clinical trials, and was found to be safe and well-tolerated. The results of the trials showed that NSI-189 had a positive effect on mood, and was associated with improved cognitive function.
NSI-189 is currently being studied for its potential to treat a variety of neurological disorders, including Alzheimer's disease, Parkinson's disease, and traumatic brain injury. It is also being studied for its potential to improve cognitive function in healthy individuals.
